Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0890
+0.0040 (4.71%)
Feb 19, 2026, 4:10 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 107.26 million as of February 18, 2026. Its market cap has decreased by -45.29% in one year.
Market Cap
107.26M
Enterprise Value
86.38M
Revenue
3.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 107.26M, an increase of 506.86%. That is a compound annual growth rate of 7.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 102.44M | -8.30% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 183.77M |
| Recce Pharmaceuticals | 170.62M |
| Actinogen Medical | 145.40M |
| Paradigm Biopharmaceuticals | 132.30M |
| Island Pharmaceuticals | 110.54M |
| LTR Pharma | 94.52M |
| Alterity Therapeutics | 92.44M |
| Cynata Therapeutics | 89.45M |